WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
South Korea · Delayed Price · Currency is KRW 8,720.00
-190.00 (-2.13%)
At close: Mar 6, 2026
KOSDAQ:330350 Market Cap
KOSDAQ:330350 has a market cap or net worth of 107.86 billion as of March 9, 2026. Its market cap has increased by 24.16% in one year.
Market Cap
107.86B
Enterprise Value
108.73B
Revenue
102.11B
Ranking
n/a
PE Ratio
17.24
Stock Price
8,720.00
Market Cap Chart
Since July 3, 2020, KOSDAQ:330350's market cap has decreased from 302.46B to 107.86B, a decrease of -64.34%. That is a compound annual growth rate of -16.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 115.12B | 1.16% |
| Dec 30, 2025 | 113.80B | 22.44% |
| Dec 30, 2024 | 92.94B | -27.60% |
| Dec 28, 2023 | 128.37B | 3.84% |
| Dec 29, 2022 | 123.62B | -10.73% |
| Dec 30, 2021 | 138.48B | -26.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyung Dong Pharmaceutical | 148.18B |
| DongKoo Bio & Pharma | 145.49B |
| KOREA PHARMA | 138.95B |
| PHARMARESEARCH BIO | 131.48B |
| HYUNDAI BIOLAND | 124.95B |
| Pharos iBio | 113.15B |
| Samik Pharmaceutical Company LTD. | 110.45B |
| H.PIO | 98.44B |